laitimes

ChiNext ETF GF (159952) rose 1.37% intraday, with a net inflow of funds for two consecutive days, with a net inflow of more than 29 million in the past 5 days, weighted shares Aier Ophthalmology rose more than 6%, and Zhifei Biotech rose more than 4%

author:Tongbi Finance

As of 10:45, ChiNext ETF GF (159952) rose 1.37% intraday, with a turnover of 65.0658 million yuan. The market is actively traded and the turnover continues to expand.

ChiNext ETF GF (159952) rose 1.37% intraday, with a net inflow of funds for two consecutive days, with a net inflow of more than 29 million in the past 5 days, weighted shares Aier Ophthalmology rose more than 6%, and Zhifei Biotech rose more than 4%

(Image source: Wind)

Among the top ten weights of the fund, Aier Ophthalmology rose by more than 6%, Zhifei Biotechnology rose by more than 4%, and individual stocks such as Zhongji Xuchuang, EVE Lithium Energy and Oriental Fortune followed suit.

ChiNext ETF GF (159952) rose 1.37% intraday, with a net inflow of funds for two consecutive days, with a net inflow of more than 29 million in the past 5 days, weighted shares Aier Ophthalmology rose more than 6%, and Zhifei Biotech rose more than 4%

(Image source: Wind)

The data shows that the ChiNext ETF GF (159952) has a net inflow of funds for two consecutive days, with a net inflow of more than 29 million yuan in the past 5 days and a net inflow of more than 530 million yuan in the past 60 days.

ChiNext ETF GF (159952) rose 1.37% intraday, with a net inflow of funds for two consecutive days, with a net inflow of more than 29 million in the past 5 days, weighted shares Aier Ophthalmology rose more than 6%, and Zhifei Biotech rose more than 4%

(Source: WIND, as of 2023.10.10)

As of October 10, the fund's share exceeded 3.032 billion, and the latest size reached 3.581 billion yuan. In addition, the ChiNext ETF GF (159952) has a lower composite rate, of which the management fee is 0.15%/year.

ChiNext ETF GF (159952) rose 1.37% intraday, with a net inflow of funds for two consecutive days, with a net inflow of more than 29 million in the past 5 days, weighted shares Aier Ophthalmology rose more than 6%, and Zhifei Biotech rose more than 4%

(Image source: wind, as of 2023.10.10)

ChiNext ETF GF (159952) closely tracks the ChiNext index. The index selects 100 stocks with large market capitalization and good liquidity in the ChiNext market as the index sample, aiming to reflect the market performance of ChiNext listed companies and provide investors with richer indexed investment tools. There are nearly 500 newly listed companies under the ChiNext registration system, accounting for nearly 40% of the total, with a total market value of more than 3 trillion yuan, accounting for more than 25% of the overall market value of the board, of which nearly 9 have become high-tech enterprises and more than 5 have become strategic emerging industry enterprises, and ChiNext enterprises have obvious advantages in innovation and growth.

CITIC Securities said that from the situation in the fourth quarter, it is expected that the economy will recover steadily, investor confidence will gradually recover, Sino-US relations will show signs of easing in stages, the Federal Reserve may not raise interest rates this year, the pressure of RMB depreciation will ease, market incremental funds will come from the floor to watch investors re-increase positions, and the marginal impact of foreign capital outflow is weakening. Finally, from the perspective of configuration strategy, it is crucial to grasp the rhythm, and it is recommended to lay out in three stages according to pro-cyclical, technological, and white horses.

ChiNext ETF GF (159952), OTC Connect (Class A: 003765; Class C: 003766).